Difference between revisions of "Fibrinogen alpha chain (TG2)"
m |
|||
| Line 2: | Line 2: | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
|- | |- | ||
| − | | align="center" colspan="2" bgcolor="#ffffff" | [[Image: | + | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Fibrinogen alpha chain.png|200px|{{PAGENAME}}]] |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| − | | | + | | Fibrinogen alpha chain |
|- | |- | ||
| Synonyms | | Synonyms | ||
Revision as of 15:16, 17 August 2007
| Template:Infobox header| Fibrinogen alpha chain (TG2) | |
|---|---|
| Fibrinogen alpha chain (TG2) | |
| Substrate peptide name | Fibrinogen alpha chain |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular; plasma |
| Swissprot ID | P02671 |
| Reactive glutamines | Q328, Q366 |
| Reactive lysines | K148, K230, K303, K413 |
| Substrate sequence | GSTGNQNPGSP
SGSTGQWHSES QLVDMKRELVD VPPEWKALTDM GTATWKPGSSG EYHTEKLVTSK |
| Structure | 1LT9 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:10816585 |
| Notes | |
| Template:Infobox header | | |
